Mol. Cells 2013; 36(4): 376-384
Published online September 16, 2013
https://doi.org/10.1007/s10059-013-0210-y
© The Korean Society for Molecular and Cellular Biology
S-adenosyl methionine (SAM) is a key intermediate in the metabolism of sulfur amino acids and is a major methyl donor in the cell. Although the low plasma level of SAM has been associated with atherosclerosis, the effect of SAM administration on atherosclerosis is not known. Endothelial dysfunction is an early prerequisite for atherosclerosis. This study was undertaken to investigate the possible preventive effect of SAM on endothelial dysfunction and the molecular mechanism of its action. SAM treatment prevented endothelial dysfunction in high fat diet (HFD)-fed rats. In cultured human aortic endothelial cells, linoleic acid (LA) increased and SAM decreased cell apoptosis and endoplasmic reticulum stress. Both LA and SAM increased heme oxygenase-1 (HO-1) expression in an NF-E2-related factor 2-dependent manner. However, knoc-kdown of HO-1 reversed only the SAM-induced pre-ventive effect of cell apoptosis. The LA-induced HO-1 expression was dependent on PPAR?, whereas SAM in-duced HO-1 in a PPAR-independent manner. These data demonstrate that SAM treatment prevents endothelial dysfunction in HFD-fed animals by inducing HO-1 in vascular endothelial cells. In cultured endothelial cells, SAM-induced HO-1 was res-ponsible for the observed prevention of cell apoptosis. We propose that SAM treatment may represent a new therapeutic strategy for atherosclerosis.
Keywords endoplasmic reticulum stress, endothelial dysfunction, heme oxygenase-1, S-adenosyl methionine, vascular endothelial cell
Mol. Cells 2013; 36(4): 376-384
Published online October 31, 2013 https://doi.org/10.1007/s10059-013-0210-y
Copyright © The Korean Society for Molecular and Cellular Biology.
Sun Young Kim, Seok Woo Hong, Mi-Ok Kim, Hyun-Sik Kim, Jung Eun Jang, Jaechan Leem, In-Sun Park, Ki-Up Lee, and Eun Hee Koh
1Department of Internal Medicine, University of Ulsan College of Medicine, Seoul 138-736, Korea, 2Asan Institute for Life Sciences, Asan Medical Center, Seoul 138-736, Korea, 3Department of Anatomy, College of Medicine, Inha University, Incheon 401-103, Korea, 4These authors contributed equally to this work.
S-adenosyl methionine (SAM) is a key intermediate in the metabolism of sulfur amino acids and is a major methyl donor in the cell. Although the low plasma level of SAM has been associated with atherosclerosis, the effect of SAM administration on atherosclerosis is not known. Endothelial dysfunction is an early prerequisite for atherosclerosis. This study was undertaken to investigate the possible preventive effect of SAM on endothelial dysfunction and the molecular mechanism of its action. SAM treatment prevented endothelial dysfunction in high fat diet (HFD)-fed rats. In cultured human aortic endothelial cells, linoleic acid (LA) increased and SAM decreased cell apoptosis and endoplasmic reticulum stress. Both LA and SAM increased heme oxygenase-1 (HO-1) expression in an NF-E2-related factor 2-dependent manner. However, knoc-kdown of HO-1 reversed only the SAM-induced pre-ventive effect of cell apoptosis. The LA-induced HO-1 expression was dependent on PPAR?, whereas SAM in-duced HO-1 in a PPAR-independent manner. These data demonstrate that SAM treatment prevents endothelial dysfunction in HFD-fed animals by inducing HO-1 in vascular endothelial cells. In cultured endothelial cells, SAM-induced HO-1 was res-ponsible for the observed prevention of cell apoptosis. We propose that SAM treatment may represent a new therapeutic strategy for atherosclerosis.
Keywords: endoplasmic reticulum stress, endothelial dysfunction, heme oxygenase-1, S-adenosyl methionine, vascular endothelial cell
Soo-Jin Lee, Sung-E Choi, Seokho Park, Yoonjung Hwang, Youngho Son, and Yup Kang*
Mol. Cells 2023; 46(8): 496-512 https://doi.org/10.14348/molcells.2023.0045Ji Ae Lee, Young-Won Kwon, Hye Ri Kim, Nari Shin, Hyo Jin Son, Chan Seong Cheong, Dong Jin Kim, and Onyou Hwang
Mol. Cells 2022; 45(3): 134-147 https://doi.org/10.14348/molcells.2021.0074Hyo-Eun Son, Hyeon-Young Min, Eun-Jung Kim, and Won-Gu Jang
Mol. Cells 2020; 43(1): 58-65 https://doi.org/10.14348/molcells.2019.0136